SCHEMBL4034019

SCHEMBL4034019

O=C(O)N1CCCC2(CCCNC2)C1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.53
NAMPT P43490 6/20 0.46
ALDH1A1 P00352 9/20 0.45
CYP3A4 P08684 8/20 0.45
CYP2D6 P10635 7/20 0.45
USP2 O75604 5/20 0.45
CYP1A2 P05177 5/20 0.45
TSHR P16473 2/20 0.42
CYP2C9 P11712 1/20 0.42
MAPK1 P28482 3/20 0.41
TP53 P04637 2/20 0.41
CYP2C19 P33261 2/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GRM5 P41594 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1222909 0.93 HSD17B10 (0.60) HSD17B10NAMPTALDH1A1CYP3A4CYP2D6
SCHEMBL4077133 0.93 CYP3A4 (0.49) HSD17B10NAMPTALDH1A1CYP3A4CYP2D6
SCHEMBL19717686 0.87 HSD17B10 (0.50) HSD17B10NAMPTALDH1A1CYP3A4CYP2D6
SCHEMBL29172879 0.87 CYP3A4 (0.42) HSD17B10NAMPTALDH1A1CYP3A4CYP2D6
Oxalic Acid SCHEMBL22409349 0.84 HSD17B10 (0.48) HSD17B10NAMPTALDH1A1CYP3A4CYP2D6
SCHEMBL18047936 0.84 HSD17B10 (0.43) HSD17B10NAMPTALDH1A1CYP3A4CYP2D6
SCHEMBL484820 0.82 HSD17B10 (0.49) HSD17B10NAMPTALDH1A1CYP3A4CYP2D6
SCHEMBL3353242 0.82 CYP3A4 (0.58) HSD17B10NAMPTALDH1A1CYP3A4CYP2D6
SCHEMBL2819024 0.82 HSD17B10 (0.52) HSD17B10NAMPTALDH1A1CYP3A4CYP2D6
SCHEMBL27036544 0.82 HSD17B10 (0.49) HSD17B10NAMPTALDH1A1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426664-B1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-06-30 EP disclosed
EP-3319960-A1 PYRIMIDINE DERIVATIVES AS BTK INHIBITORS AND USES THEREOF Merck Patent GmbH (DE) 2018-05-16 EP disclosed
WO-2017007987-A1 PYRIMIDINE DERIVATIVES AS BTK INHIBITORS AND USES THEREOF MERCK PATENT GMBH (DE) 2017-01-12 WO disclosed
WO-2009102537-A1 INHIBITORS OF CHECKPOINT KINASES MERCK & CO., INC. (US) 2009-08-20 WO disclosed